-
Patient info
-
»Active substances
Active substances
- Burosumab
- busulfan
- C1 inhibitor (human)
- cabazitaxel
- cabergoline
- Cabotegavir sodium, Cabotegravir
- cabozantinib
- cabozantinib (s)-malate
- Caffeine citrate
- canagliflozin
- canagliflozin, metformin hydrochloride
- Canakinumab
- cangrelor
- canine distemper virus, strain CDV Bio 11/A, canine adenovirus type 2, strain CAV-2 Bio 13, canine parvovirus type 2b, strain CPV-2b Bio 12/B and canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (all live attenuated)
- canine distemper virus, strain CDV Bio 11/A, canine adenovirus type 2, strain CAV-2 Bio 13, canine parvovirus type 2b, strain CPV-2b Bio 12/B, canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (all live attenuated), Leptospira interrogans serogroup
- Canine herpesvirus (F205 strain) antigens
- canine parainfluenza type-2 virus, strain CPiV-2 Bio 15 (live attenuated)
- Canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (live attenuated), Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L.
- canine parainfluenza virus, leptospira and rabies virus.
- Cannabidiol